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482: A nonsynonymous SNP in CYP1B1 is associated
with primary open angle glaucoma
1Deblina Banerjee, 1Ashima Bhattacharjee, 1Suddhasil Mookherjee,
1Moulinath Acharya, 1Antara Banerjee, 1Ananya Ray, 2Abhijit Sen,
3The Indian Genome Variation Consortium, 1Kunal Ray
1Molecular and Human Genetics Division, Indian Institute of
Chemical Biology (CSIR), Kolkata, India, 2Dristi Pradip, Jodhpur
Park, Kolkata, India, 3Nodal Laboratory, Institute of Genomics and
Integrative Biology (CSIR), Delhi, India
Primary open angle glaucoma (POAG) is the most prevalent of the
glaucoma subtypes. The disease is known to be transmitted mostly as
a complex disease. Though CYP1B1 is primarily known to cause
primary congenital glaucoma, defects in the gene have also been
reported to cause POAG by either serving as a modifier locus and on
rare occasions as a primary locus. POAG primarily being a complex
disease, we speculate that CYP1B1 might have a wider role in its
pathogenesis, which prompted us to examine the potential for asso-
ciation of single nucleotide variations in the gene with the disease.
Towards this goal we examined a few cSNPs in the gene for their
potential role in POAG. Comparison of the allele frequencies of such
SNPs among patients and controls revealed that for the Leu432Val
polymorphism Val432 (c.1666G) allele is significantly over repre-
sented among POAG patients (p value: 0.0001. Odds ratio: 6.027,
95% CI: 3.863–9.401) suggesting it to be a potential risk allele
towards disease predisposition. Analysis of genotype frequencies of
the polymorphism between the two groups demonstrated GG as a
potential risk haplotype (p value: 0.0001, Odds ratio = 15.505, 95%
CI: 5.529–43.474) for the disease. CYP1B1 Val432 was estimated to
generate higher reactive super oxides (ROS) in RPE cells compared to
its allelic variant (Leu432). It has been reported that the allele
resulting Val432 isoform has higher ability for 4-hydroxylation of 17
beta estradiol which generates higher ROS in cells. Oxidative stress
generated by ROS can lead to the damage of the retinal ganglion cells
leading to glaucoma. Therefore, inter-individual differences in
estrogen metabolism resulting from the Leu432Val variant in
CYP1B1 may lead to differences in susceptibility to complex diseases
like POAG. Moreover, the prevalent haplotype CGGTA for CYP1B1
locus among POAG patients was found to be the same as that reported
in PCG patients harboring CYP1B1 mutations (p value: 0.0001, by
Fisher’s exact test). Studies are in progress to measure enzymatic
activity and protein expression of CYP1B1 in the background of
major haplotypes to elicit more complete information on molecular
basis of POAG pathogenesis led by CYP1B1. The study is supported
by funds provided by council of scientific and industrial research
(CSIR), Govt. of India.
483: Involvement of IL1 gene cluster in glaucoma
pathogenesis
1Subhadip Chakraborty, 1Suddhasil Mookherjee,
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1Molecular and Human Genetics Division, Indian Institute of
Chemical Biology (CSIR), Kolkata, India, 2Dristi Pradip, 385,
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Glaucoma is a group of neurodegenerative disorder of eye and the
second leading cause of blindness worldwide after cataract. Recent
evidences suggest a possible role of immune system in glaucoma
pathogenesis. Studies indicate that several SNPs in the interleukin 1
gene have either protective or adverse effect on primary open angle
glaucoma (POAG)—the major subtype of glaucoma across globe. So
we intended to investigate the role of these SNPs in a group of eastern
Indian POAG patients. Towards this goal we genotyped three SNPs in
IL1 gene cluster (rs1800587, rs16944 and rs1143634) consisting of
two promoter SNPs (IL1A -889C/T, IL1B -511T/C) and a coding
SNP (IL1B + 3953C/T) in 332 unrelated POAG patients and 111
controls by PCR–RFLP analysis. The allele and genotype frequencies
were determined for comparison between the cases and controls;
similarly distribution of haplotypes (consisting of these three SNPs)
was estimated between the two groups using HaploView 3.32. Since
POAG consists of high tension glaucoma (HTG) and normal tension
glaucoma (NTG), which is distinguished by the intra-ocular pressure,
we conducted similar exercise for HTG (n = 124) and NTG (n = 208)
patients in our POAG cohort. Significant difference was observed in
the genotype and allele frequency distribution between NTG patients
and control group for IL1A (-889C/T) SNP. Thus, IL1A -889C
allele was significantly over represented in NTG patient cohort [p
value = 0.031, OR (95% CI) = 1.496 (1.052–2.126)] and the patients
carrying the CC genotype were in greater risk for having NTG [p
value = 0.019, OR (95% CI) = 1.790 (1.125–2.847)]. Also, haplo-
type analyses revealed a statistically significant biased distribution of
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CTC haplotype in the NTG patients, which pose a risk for the disease.
Thus our study suggests that IL1 gene cluster is possibly involved in
normo-tensive glaucoma pathogenesis in eastern Indian patients,
which need to be further vindicated by similar studies using larger and
additional cohort of POAG patients. This study is supported by funds
from council of scientific and industrial research (CSIR), Govt. of
India.
484: Association of MAPT haplotype-tagging SNPs
with Parkinson’s disease among Indians
1Gautami Das, 2Shyamal K. Das, 3Kunal Ray, 1Jharna Ray
1S.N. Pradhan Centre for Neurosciences, University of Calcutta,
Kolkata, India, 2Bangur Institute of Neuroscience and Psychiatry,
Kolkata, India, 3Indian Institute of Chemical Biology (CSIR),
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Parkinson’s disease (PD) is a progressive neurodegenerative disorder
of the central nervous system characterized clinically by a movement
disorder manifesting as rest tremor, bradykinesia, rigidity and postural
instability. Significant differences in the reported prevalence of PD in
different countries worldwide suggest ethnic and/or environmental-
associated multigenic contributions to this disease. Microtubule
associated protein tau (MAPT) gene encodes for a phosphorylated
protein, tau that regulates neuronal microtubule dynamics and
assembly. Tau has been reported to co-aggregate with a-synuclein in
Lewy bodies (LB) in post mortem brain of PD patients indicating its
role in the disease process. Association of MAPT with PD among
Caucasians has been extensively studied but till date no such study
has been done among Indian PD patients. Here we have examined the
possible genetic role of MAPT with PD using haplotype-tagging
SNPs (rs1467967, rs242557, rs2471738 and rs7521) and the 238 bp
deletion–insertion polymorphism, del-In9 of MAPT in 213 clinically
confirmed PD patients and 209 healthy controls of India. In the single-
locus association analysis, we did not find any significant difference
in genotype or allele distribution between cases and controls. How-
ever, on comparing the allele frequencies of the del/In9 between late
onset PD patients (age at onset C50 years) and early-onset PD (age at
onset \50 years) a marginal significance was observed (p = 0.035;
Odds ratio = 2.451; 95% CI: 0.996–6.03) implying that this deletion
is a risk in late onset PD. Comparison of the haplotype diversities
revealed a single risk haplotype (GAC + G) among Indian PD
patients (p = 0.042; Odds ratio = 1.577; 95% CI: 1.03–2.42). Our
study supports the role of genetic variability in MAPT in the etiology
of PD among Indians which requires to be further explored by rep-
licating the study in larger and additional cohort. This study is
supported by CSIR, Govt. of India.
485: Analysis of association between genetic
polymorphisms and aggressive traits in intellectually
disabled individuals from eastern India
Aneek Das Bhowmik, Swagata Sinha, Kanchan Mukhopadhyay
Manovikas Biomedical Research and Diagnostic Centre, 482,
Madudah, Plot I-24, Sector J, Eastern Metropoliton Bypass,
Kolkata 700107, India
Intellectual and developmental disabilities are the most common
neurological problem affecting 1–3% of the world population.
Cognitive impairment along with neuromotor dysfunction is also
frequently observed in Down syndrome patients. Influence of
dopaminergic and serotoninergic neurotransmission on cognition is
well known and monoamine oxidase A (MAOA) plays an important
regulatory role in maintaining the level of these neurotransmitters.
In the present investigation, three variable number of tandem repeats
(VNTR) in the dopamine receptor D4 (DRD4 exon3 48 bp VNTR),
serotonin transporter (SLC6A4-5HTTLPR) and MAOA (MAOA-
uVNTR) have been analyzed in subjects suffering from various
levels of intellectual disability. Intellectually challenged individuals
were recruited following the criteria mentioned by diagnostic and
statistical manual of mental disorders (DSM-IV) and classified based
on the intelligent quotient (IQ). Control individuals belonging to the
same ethnic group were also recruited after evaluation. Peripheral
blood was collected, after obtaining informed written consent, for
isolation of genomic DNA to be used for PCR-based amplification
of target sites and analysis. By both case–control and family-based
association methods, no significant contribution of the DRD4 ex3
VNTR was observed (p [ 0.1). The 5HTTLPR and MAOA-uVNTR
also failed to show any significant difference between control and
intellectually challenged subjects (p [ 0.4 and 0.3 for 5HTTLPR
and MAOA-uVNTR, respectively). However, a trend towards
association with the shorter repeats of the MAOA-uVNTR was
noticed in a sub-group of intellectually disabled people with
aggressive behavior (p \ 0.05). For the first time, association of
these polymorphisms in individuals with intellectual disability have
been explored and the data obtained revealed significant contribution
of the MAOA-uVNTR in the behavioral attributes of intellectually
challenged individuals while no significant correlation was noticed
with the level of IQ.
Acknowledgement: This study was partly sponsored by ICMR, Govt.
of India (Project No. 5/4-4/11/M/2003-NCD-I) and partly by Board of
Trustees, Manovikas Kendra, Kolkata.
486: In silico analysis reveals pyrroloquinoline
quinine is an effective ligand for a—synuclein—a
key player in Parkinson’s disease
Sayak Ganguli, Sangeeta Mondal, Abhijit Datta
Bioinformatics Infrastructure Facility, Presidency College,
86/1College Street, Kolkata-700073, India
Alpha-synuclein is a member of the synuclein family, which also
includes beta- and gamma-synuclein. Synucleins are abundantly
expressed in the brain and alpha- and beta-synuclein inhibit phos-
pholipase D2 selectively. SNCA may serve to integrate presynaptic
signaling and membrane trafficking. Three novel missense mutations
as well as gene triplication genetically link the 140-residue protein —
synuclein at A30P (VAR_007957), E46K (VAR_022703) and A53T
(VAR_007454) believed to cause Familial Early-Onset Parkinson’s
Disease. Analysis of the SNCA exon showed a GCA to CCA
nucleotide substitution in codon 134, GAG to AAG nucleotide sub-
stitution in codon 182 and GCA to ACA, nucleotide substitution in
codon 203 of the SNCA gene, causing amino acid substitutions of Ala
to Pro (A30P), Glu to Lys (E46K), and Ala to Thr (A53). These point
mutations show heterozygosity and have definite roles in determining
protein secondary structure conformation and abnormal folding of
non-beta amyloid protein, whose function is unclear but thought to be
involved in neuronal degeneration causing a loss of dopamine syn-
thesis. Homology modeling of three variants shows slight difference
in Ramachandran plot values at corresponding mutated residues
which provide valuable information about their structural backbone
orientation. It was shown that neither the A53T nor the A30P
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mutation has a significant effect on the structure of the folded protein,
although the A30P mutation may cause a minor perturbation in the
helical structure around the site of the mutation. a-Synuclein is a
Parkinson’s disease-related protein. It forms aggregates in vivo, and
these aggregates cause cell cytotoxicity. Aggregation inhibitors are
expected to reduce a-synuclein cytotoxicity, and an aggregation
accelerator has recently been reported to reduce a-synuclein cyto-
toxicity. Agents that prevent the formation of amyloid fibrils might
allow a novel therapeutic approach to PD. The results of the current
study indicate that Pyrroloquinoline quinine and its derivatives might
serve as effective ligands for alpha—synuclein thus reducing its
cytotoxic effects.
487: A study of GRIK1 gene polymorphism
in mental retardation related to Down syndrome
1Debarati Ghosh, 2Swagata Sinha, 2Anindita Chatterjee,
1Krishnadas Nandagopal
1Manovikas Biomedical Research and Diagnostic Centre,
482 Madudah, Plot-I-24, Sector-J, Eastern Metropolitan Bypass,
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Background: Down syndrome (DS) is the most common genetic cause
of mental retardation (MR). The inheritance of a risk allele by non-
disjunction from a heterozygous parent results in the DS offspring
being homozygous for the risk allele. This increases susceptibility to
mental retardation. The kainate subtype glutamate receptor subunit
GluR5, encoded by the GRIK1 gene on chromosome 21q22.1, is a
candidate gene for MR in DS and is expressed in brain regions
responsible for learning and memory. Single nucleotide polymor-
phisms in GRIK1 could increase susceptibility to DS related MR.
Aim: We wished to identify non-disjoining/risk allele(s) of GRIK1 in
Down syndrome individuals and the parent/stage of origin of non-
disjunction in patient families.
Methods: Three single nucleotide polymorphisms [522(A/C), 1173(C/
T) and 2705(T/C)] in GRIK1 were genotyped by PCR–RFLP assay in
255 healthy individuals and 61 DS patient families (trios). Of the
polymorphisms studied, 1173(C/T) is the most informative marker
due to its heterozygosity (0.341) and population specific difference in
major allele frequency. Out of 61 families, 40 families were geno-
typed for 1173(C/T) where at least one parent is heterozygous and
parent to offspring allelic transmission could be studied. In 40 fam-
ilies, 19 families with homozygous probands were informative where
non-disjoining allele and parent/stage of origin could be determined.
The study was further extended by including the other two markers
that were significantly in linkage disequilibrium with 1173(C/T)
polymorphism.
Results: ‘C-1173’ is non-disjoining allele in 18/20 cases whereas
‘T-1173’ is non-disjoining allele in 1/20 cases. So, ‘C-1173’ is the
risk allele. Out of 18 cases, the risk allele arises from maternal
meiosis I (10/18), paternal meiosis I (5/18) and meiosis II (3/18) with
parent of origin unknown. For all three markers, most (8/11) of the
non-disjunction error occurred in meiosis I in mothers aged between
25.5 and 35.5 years.
Conclusion: The non-disjoining C-1173 risk allele shows biparental
mode of origin with errors occurring in meiosis I and II. Maternal age
between 25.5 and 35.5 years is risk for meiotic non-disjunction error.
Acknowledgements: Debarati Ghosh is the recipient of a Junior
Research Fellowship from SERC-DST grant SR/SO/HS-59/2003
awarded to Krishnadas Nandagopal.
488: Neural tube defects in India occur despite
normal maternal folate status and low frequency
of T allele at C677T polymorphism in the MTHFR gene
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India has a high projected burden of neural tube defects (NTDs) and
incidence in some states is reported to be as high as 11.4/1,000 births.
Despite this, no study has systematically probed into the nutritional or
genetic etiology of NTDs. We present an interim report of our 3-year,
multi-centre case–control study funded by the Department of Bio-
technology to investigate the genetic susceptibility to neural tube
defects and its association with maternal vitamin B12 and folate status
involving subjects from four cities in four different states. During the
period of January 2007 to May 2008, 132 NTD case trios (offspring
and both parents) were enrolled. Plasma folate concentrations were
normal (more than 7 nmol/l) in 93.5% mothers, while 36.7% had low
(less than 150 pmol/l) plasma vitamin B12 concentration and 45.6%
had hyperhomocysteinemia (more than 10 mmol/l). Folate deficiency
contributed only 4.6% to the risk of hyperhomocysteinemia while
vitamin B12 deficiency contributed 29.73% (population attributable
risk). Frequency of the risk allele ‘T’ at the C677T polymorphism was
13.3% in mothers with NTD fetuses and 13.4% in control mothers.
The homozygous TT genotype was present in two case and control
fetuses each but in none of the mothers in the study. No evidence of
preferential transmission of the T allele to the affected fetus from
mothers was noted. Our results suggest for the first time that folate
deficiency and the predisposing MTHFR C677T polymorphism has a
limited contribution to the etiology of NTDs in India. Thus, it may be
important to look beyond folate and MTHFR C677T polymorphism
for exploring the etiology of NTDs in India. We will have an
opportunity to study whether vitamin B12 deficiency contributes to
this problem and also to study the role of gene–gene and gene–
nutritional interaction.
489: Preliminary analysis of SLC6A4 gene
polymorphisms indicates the possibility of a positive
association of the gene with autism in Indian population
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Dysfunction of serotoninergic neurotransmission has long been
implicated in autism. The presence of platelet hyperserotoninemia in
25–30% of the autistic children, the role of serotonin transporter
Genomic Med. (2008) 2:389–400 391
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(SERT) in the regulation of serotonin uptake, betterment of ritualistic
behavioral symptoms in autism by selective serotonin reuptake inhib-
itors (SSRI) and location of SLC6A4, the gene that codes for SERT to
autism critical region on chromosome 17q11 put forth the notion that
SLC6A4 can be a potential candidate gene for autism. However, in the
present scenario, we have only very little information available on the
association of this gene with autism in the Indian population. There-
fore, in the present study we investigate the possible genetic association
of two markers of SLC6A4 gene [a 17 bp VNTR at intron2 (STin2) and
an G/T SNP at 30UTR (HTT-30UTR-SNP)] with autism in the Indian
population employing family and population-based approaches. Study
subjects were recruited after a detailed psychometric evaluation fol-
lowing the criteria of DSM-IV by a panel of psychiatrist, clinical
psychologist and pediatrician. On the basis of assessment using CARS,
93 autistic subjects with their parents and 104 controls were selected for
the genotyping analysis. The genotypic and allelic frequencies of all the
groups conformed to Hardy–Weinberg Equilibrium. The family-based
association studies using the two markers (STin2 and HTT-30UTR-
SNP) did not show any preferential transmission of alleles and specific
haplotypes from parents to the affected children. Interestingly from our
analysis using the cases and control subjects from West Bengal state in
India, we observed a contrasting linkage disequilibrium (LD) pattern
showing strong LD (D0 value = 0.82, r2 = 0.34) in the autistic group
compared to the control individuals (D0 value = 0.27, r2 = 0.05)
along with a disease-specific distortion of specific haplotypes formed
between the two markers (LRS = 11.85, p = 0.02). These findings
indicate suggestive evidence towards association of these markers of
SLC6A4 or any other nearby markers with autism in the Indian pop-
ulation. The replication of the study in other populations and using
wider sample size is warranted to corroborate our present preliminary
finding of positive allelic association.
Acknowledgement: The financial support from CSIR is gratefully
acknowledged.
490: Contributions of the ARMS2 (LOC387715)
and HTRA1 variants in the risk of age-related macular
degeneration among Indian patients
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Objectives: Single nucleotide polymorphisms (SNPs) in the ARMS
(LOC387715) (rs10490924), HTRA1 (rs11200638) and CFH
(rs1061170) genes have been implicated in age-related macular degen-
eration (AMD). The present study was undertaken to understand the
involvement of the ARMS2 and HTRA1 in an AMD cohort from India.
Methods: The coding region of ARMS2 (exon I) and the promoter of
HTRA1were screened by resequencing in AMD cases (n = 250) and
normal controls (n = 250). Odds ratios were calculated to assess the
risk of individual genotypes. Linkage disequilibrium (LD) and hap-
lotype frequencies were estimated with Haploview software.
Population attributable risk (PAR%) for the associated SNPs and their
combined effects were calculated. Meta analysis of the associated
SNPs was done across different studies.
Results: Significant associations were noted with the risk alleles of
rs10490924 (‘T’ allele; p = 5.34 9 10-12) in ARMS2, and rs11200638
(‘A’ allele; p = 4.32 9 10-12) and rs2672598 (‘C’ allele;
p = 3.39 9 10-11) in HTRA1 amongst the cases. Correspondingly, the
homozygous risk genotypes ‘TT’, ‘AA’ and ‘CC’ in these SNPs
exhibited higher disease odds and PAR%. The rs10490924 and
rs11200638 were in tight LD (D0 = 0.90, 95%CI 0.84–0.93). The
‘G-C-T-A-C’ was the risk haplotype (p = 8.04 9 10-15), while the
‘G-C-G-G-T’ haplotype was protective (p = 2.01 9 10-4). The
combined effect of CFH (CC) and ARMS2 (TT) risk genotypes
exhibited a PAR of 93.7% (OR = 73.89, 95%CI, 8.69–628.13). Meta
analysis reinforced the earlier findings that the rs10490924 (ARMS2)
risk genotype TT contributed to an increased risk of AMD (pooled
OR = 8.13, 95%CI, 6.82–9.68) compared to a single copy (pooled
OR = 2.47, 95%CI, 2.23–2.74) of the risk (T) allele.
Conclusions: The ARMS2 (rs10490924) SNP conferred a higher
susceptibility to AMD than the HTRA1 SNPs, as evident from
genotype, haplotype and Meta analysis. Overall, these results under-
score the functional importance of these SNPs in AMD pathogenesis
and provide their risk estimates in the Indian cohort that may be
useful for predictive testing.
491: The influence of SLC6A3 and DRD2 genes
variation on personality traits modified
by gender—ethnicity confounding
1Anastasiya Kazantseva, 2Daria Gaysina, 1Elza Khusnutdinova
1Institute of Biochemistry and Genetics, Ufa Scientific Center,
Russian Academy of Sciences, 71, Prospekt Oktyabrya, Ufa 450054,
Russia, 2MRC SGDP Centre, Institute of Psychiatry, King’s College
London, De Crespigny Park, London SE5 8AF, United Kingdom
Individual differences in personality were reported to be influenced
by both environmental and genetic factors. Psychobiological model
proposed by Cloninger supposes that sociability related personality
traits are mediated by dopaminergic system functioning. It has been
accepted now that complex phenotypes, such as personality traits, are
presumably affected by the interaction of multiple genes of small
effect. Such factors as age, ethnicity and gender, cultural and envi-
ronmental conditions could also contribute into variation of
personality. We aimed to define a possible epistasis of DRD2 TaqIA
and SLC6A3 MspI polymorphisms, considering gender and ethnicity
as confounding factors, on personality traits (assessed with the EPI
and TCI questionnaires) via linear regression analyses. We recruited
602 healthy individuals (men-206, women-396) of Caucasian origin
(Russians-214, Tatars-388) from Russia (mean age ± SD, 19.85 ±
2.43 years). In the present study gender and ethnicity differences in
personality were observed: women scored significantly higher on
Neuroticism, Novelty Seeking (NS), Harm Avoidance (HA) and
Reward Dependence compared to men; Russians reported higher
scores on Extraversion and NS scale, while Tatars revealed higher
HA. Although both DRD2 TaqIA and SLC6A3 MspI polymorphisms
might be involved in dopaminergic activity regulation, gene–gene
interaction has not been demonstrated. However, DRD2 and SLC6A3
gene effects were revealed in relation to neuroticism (F = 19.10;
P \ 0.0001) and NS (F = 13.97; P \ 0.0001) correspondingly, while
adjusting for such confounding factors as gender and ethnicity,
explaining 8.5 and 6.6% of variation in these personality traits. On the
other hand, we observed SLC6A3 main effect on NS (F = 4.15;
P = 0.042) and persistence (F = 5.40; P = 0.020) contributing to 0.5
and 0.7% of variation, correspondingly. Since DRD2 TaqIA A1-allele
has been reported to result in decreased dopaminergic activity, our
findings allow supposing that dopamine excess in synapse could
predispose to enhanced anxiety-related traits. Since regression models
involving DRD2 and SLC6A3 genes were demonstrated to influence
different personality traits, polygenic cause of personality was
approved indicating that a single neurotransmitter in a some extent
can influence multiple personality traits. This work was supported
by Russian foundation for humanities grants (06-06-00163a,
392 Genomic Med. (2008) 2:389–400
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08-06-00579a) and Russian Science Support Foundation (to A.
Kazantseva, D. Gaysina).
492: High prevalence of infantile encephalitic beriberi
with overlapping features of Leigh’s disease
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Infantile encephalitic beriberi (IEBB), a rare form of thiamine defi-
ciency is poorly described. The clinical picture and the imageological
findings of IEBB are known to overlap with Leigh’s disease (LD),
which is a progressive neurometabolic disorder usually presenting in
the infancy. Similar to a dramatic response to thiamine supplemen-
tation in beriberi, a type of LD due to pyruvate dehydrogenase
deficiency responds equally well to treatment with thiamine. Due to
these overlapping features, the two conditions are commonly mis-
diagnosed unless one has good clinical acumen and shows high index
of suspicion. Thiamine deficiency has been a problem of developing
countries but as per reports from nutritional foundation of India in
2004 and 2007, India has eliminated it through programmes such as
under milling of rice. Similarly, there are few cases of LD that have
been explored in India. Thus, data on both IEBB and LD is scarce and
status of thiamine deficiency in India is controversial.
We report 165 infants with life-threatening respiratory and central
nervous system symptoms who were remarkably responsive towards
large dose of thiamine. All the patients underwent detailed clinical,
biochemical and imageological investigations. Thiamine status was
analyzed by estimating erythrocyte transketolase (TK) levels. Common
clinical manifestations included altered sensorium, external ophthal-
moplegia, seizures, hypotonia, irregular sighing or sobbing respiration,
which are common in IEBB and LD. Serum and CSF lactate levels were
high and TK levels were less in most of the infants. CT scan/MRI/MRS
together showed abnormal brain imaging and lesion in basal ganglia.
Imageological observations were also common in both the phenotypes.
Several patients were followed up at different time intervals with
specific stress on clinical evaluation and neuro-imageological investi-
gations were repeated on few of them. On follow-up, majority of them
had complete resolution of the brain lesions, corroborated by clinical
improvement; however, many had persistent neurological and ima-
geological abnormalities. It suggested that these patients may be of LD
patients where other than thiamine deficiency, genetic factors were also
playing role in disease manifestation. Our study highlights the impor-
tance of thiamine deficiency in India, especially in the breast-feds and
its overlapping features with LD. Awareness of this common mode of
presentation may save patients’ lives by early diagnosis and timely
thiamine supplementation.
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Systemic lupus erythematosus (SLE) is an autoimmune disease,
characterized by the production of antinuclear antibody or ANA due
to abnormalities of the immune system. SLE is not only a multifac-
torial disorder but also a polygenic and complex disease. SLE can
cause renal failure, vasculitis, arthritis, thrombosis, seizures, and other
neurological complications. The disease is believed to be triggered by
genetic defects, environment, viral and bacterial infection.
In this study we characterized PDCD1 polymorphic genes and
investigated their association in a cohort of Malaysian (Malays and
Chinese) SLE patients. The most common PDCD1 genotypes found
in SLE patients were PD-1.1 (G/G), PD-1.2 (A/G), PD-1.3 (G/G),
PD-1.4 (A/G), PD-1.5 (C/T) and PD-1.6 (A/G), with frequencies
ranging from 40 to 100%. However, PD-1.3 (G/G), PD-1.4 (A/G)
and PD-1.6 (A/G) were also commonly found in control individuals
with frequency distributions ranging from 60 to 97%. Positive
associations with the SLE phenotype were found for PD-1.9 (C/T),
PD-1.5 (C/T) and PD-1.6 (A/A), while negative associations of PD-
1.2 (G/G) (39 vs. 53.4%), PD-1.3 (A/G) (0 vs. 3.4%), PD-1.9 (C/C)
(23.5 vs. 48.3%) and PD-1.5 (C/C) (41 vs. 62.4%) were observed.
The contradictory result from the previous study probably reflects
population differences in the haplotype structure of the PDCD1
locus.
494: Functional implication of CYP1B1 in primary
open angle glaucoma
Suddhasil Mookherjee, Moulinath Acharya, Ashima Bhattacharjee,
Deblina Baneerjee, Kunal Ray
Molecular and Human Genetics Division, Indian Institute
of Chemical Biology (CSIR), Kolkata, India
Primary open angle glaucoma (POAG) is the most prevalent of the
glaucoma subtypes and is transmitted mostly as a complex disease.
Though CYP1B1 gene has been implicated in primary congenital
glaucoma with autosomal recessive mode of inheritance, genetic
studies suggests a role of this gene in primary open angle glaucoma
(POAG) as a modifier along with Myocilin (MYOC), one of the well-
characterized candidate for POAG. Recent evidences also suggest on
rare occasions defects in CYP1B1 alone can cause POAG in auto-
somal recessive mode. However, functional assessment of its
involvement in POAG has not yet been investigated. We sought to
investigate the role of this gene in primary open angle glaucoma.
Myocilin promoter region containing ERE (estrogen responsive ele-
ment) and AP1 sites were cloned into promoterless pGL3 vector
containing luciferase reporter gene. The constructs were transfected in
RPE (retinal pigment epithelium) cells followed by treatment with
17b estradiol in a dose and time dependent manner. Consistent
estradiol mediated induction was observed in the largest ‘MYOC
promoter—pGL3 construct’ containing all three EREs as measured by
luciferase assay. We propose that 17b estradiol can induce MYOC
expression through the putative EREs located in its promoter and
CYP1B1 could manipulate MYOC expression by converting 17b
estradiol into 4-hydroxy estradiol, thus preventing it from binding to
MYOC promoter. Hence any mutation in CYP1B1 that reduces its
enzymatic activity can induce glaucoma pathogenesis by over
expression of MYOC. The mutant CYP1B1 clones were generated
and the enzymatic activity of each mutant was measured. The
expression of endogenous MYOC was analyzed in the background of
the CYP1B1 mutants in trabecular meshwork cell line. It was found
that indeed CYP1B1 mutant is responsible for over expression of
endogenous MYOC. Thus our experimental observation is consistent
with our proposed hypothesis that mutant CYP1B1, which lacks the
17b estradiol metabolizing activity can induce, glaucoma by over
expression of MYOC. (This study is supported by Council of
Scientific and Industrial Research, Govt. of India).
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495: A putative genetic locus for bipolar affective
disorder at chromosome 6pter-p24.3
1A. Ram Murthy, 2R. Ratnapriya, 1Shobana Kubendran,
1Valli K. Manduva, 1Meera Purushottam, 1Y. C. Janardhan Reddy,
1Sanjeev Jain, 2Anuranjan Anand
1National Institute of Mental Health and Neuro Sciences
(NIMHANS), Department of Psychiatry, NIMHANS, Bangalore,
India, 2Jawaharlal Nehru Centre for Advanced Scientific Research
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Jakkur, Bangalore, India
Bipolar affective disorder (BPAD) is a common psychiatric disorder
characterized by episodes of mania and depression with worldwide
prevalence of 1%. To identify a genetic locus for BPAD we have
studied a family of 19 individuals, of which nine were affected with
the disorder. We examined 381 microsatellite markers, spaced at an
average resolution of 10 cM in the family members. For the dominant
model of inheritance, three regions provided two-point LOD scores of
C1.2. These were, D6S1574 on 6p25.1 (LOD score 1.23, h = 0.1);
D6S462 on 6q15 (LOD score 1.26, h = 0.0) and D11S1338 on
11p15.4 (LOD score 1.4, h = 0.1). These three sub-genomic regions
were followed up using 38 additional markers located at B2 cM
resolution. Manual haplotype analysis showed a 10-marker haplotype
shared among eight affected individuals of the family which extends
from 6pter to 6p24.3 (D6S1640) and comprises of 7.35 mega bases of
DNA. Multipoint analysis of the markers in the region provided
highest NPL of 3.007 (p = 0.017). Analysis of these additional
informative markers ruled out possibility of linkage to the regions 6q
and 11p. We also examined 11 families with similar BPAD phenotype
for markers from the haplotype on 6p. Haplotype analysis in the
additional families showed haplotype sharing in two families, with all
four affected individuals sharing in one family and three among four
affected individuals in other family. Two-point LOD score of 2.15
was obtained for D6S1591 (h = 0.1) at 6p25.1 in the combined
analysis of the three families. When Psychosis NOS was included in
the phenotype classification, two-point LOD score of 2.51 was
obtained for D6S1591 (h = 0.1). Involvement of the 6pter-p24.3
region has previously been shown in bipolar and schizophrenia
cohorts from European, Irish, Old Older Amish, Austria, Caucasian,
Swedish and Eastern Quebec populations. Our results suggest exis-
tence of a genetic locus for BPAD at the same region on chromosome
6pter-p24.3. In search of causative mutations, analysis of candidate
genes, NRN1, SLC22A23, NQO2, TUBB2A and TUBB2B is being
taken up.
496: Association studies of neurotransmitter
receptor and transporter genes in the theranostics
of schizophrenia in a South Indian population
1N. V. Neetha, 1K. V. Linda, 1N. Chandrasekhar, 1Mathew Anila,
2Nair Chandrashekharan, 3Allencherry Priya, 1Banerjee Moinak
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2Nairs Hospital, Kochi, Kerala, India, 3Mental Health Centre,
Trivandrum, Kerala, India
Schizophrenia is a debilitating psychiatric disorder with a prevalence
of 2.2 per 1,000 adults in India. Disturbances in dopamine and
serotonin neurotransmitter is hypothesized to cause schizophrenia.
Polymorphisms in these genes can affect individuals response to
therapeutic agents. Understanding the pharmacogenetics of these
genes have implications for therapeutic effects, abusepotential and
side effects of these drugs. In this study we examined the role of
19SNPs in Dopamine receptor D3 (DRD3), Dopamine receptor D4
(DRD4), Dopamine transporter (SLC6A3), Serotonin receptor 1B
(HTR1B), Serotonin receptor 6 (HTR6), Serotonin receptor 2A
(HTR2A), Serotonin receptor 3B (HTR3B) and Serotonin transporter
(SLC6A4) genes in schizophrenia; in the presentation of symptom
and antipsychotic treatment response in South Indian population.
Subjects included 243 schizophrenic patients and 243 ethnically and
age-matched controls. Patients were assessed using BPRS. Clinical
improvement was assessed by percent impovement after 1 year fol-
low-up. H–WE allele and genotype frequency was calculated with
COCAPHASE and LD pattern with Haploview. DRD4rs936461 is
associated with of disorganized behavior (p = 0.0153), conceptual
disorganization (0.134), motor retardation (0.012), tension
(p = 0.022) and uncooperativeness (p = 0.01). Association was
observed with DRD4rs936460 with somatic concern (p = 0.05) and
DATrs2652510 with motor retardation. 5HT2AS1438 and 102T/C
polymorphism influenced self neglect (p = 0.02), blunted effect
(0.05) and motor retardation (p = 0.04). SLC6A4 polymorphism was
significantly associated with schizophrenia. 12rpt allele and 12/12
genotype was over represented in cases when compared to controls
(p = 0.002). DRD4rs936460 T allele was over represented in cases
(p = 0.07). A significant difference in haplotype frequency was noted
in the serotonin transporter gene with C-12 haplotype over repre-
sented in cases (p = 0.009). No significant association of the
polymorphisms with antipsychotic treatment response was observed.
This suggests that neurotransmitter receptor and transporter gene
polymorphisms screened alone is not involved in complex antipsy-
chotic drug response profile in this population. The study reports
significant association with SLC6A4. The difference in the presen-
tation of symptoms in schizophrenic patients throughout the world,
influenced by the sociocultural factors like ethnicity could prove vital
in solving the present chaos in the field of psychiatric genetics.
497: Molecular correlates of extreme human
constitution types defined in Ayurveda: the Indian
traditional system of medicine
1Sapna Negi, 1Bhavana Prasher, 1Shilpi Aggarawal, 1Amit Mandal,
2Sudha Purohit, 2Shailaja Deshmukh, 1The Indian Genome Variation
Consortium, 1Samir Brahmachari, 1Mitali Mukerji
1Institute of Genomics and Integrative Biology (CSIR), Functional
Genomics Unit, Institute of Genomics and Integrative Biology
(CSIR), Delhi, India, 2University of Pune, Department of Statistics,
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Genome wide expression as well as nucleotide variation studies
reveals that most genetic variation is due to inter-individual differ-
ences at genetic loci even within populations. The enormous
heterogeneity within population is largely responsible for the limited
success and replication of genome wide association studies towards
capturing markers associated with complex diseases, even when
applied on large sample sizes. Key to this is to capture phenotypic
uniformity with greater precision to get more uniform genetic back-
ground. This study is a step towards the same. In the Ayurveda system
of medicine, method for phenotypic assessment of a person, which
includes one’s body constitution, has been described. In the present
study only extreme constitution types from Indian populations of
Indo-European origin, are considered. The peripheral blood samples
were analyzed for genome wide expression and nucleotide variations
in genes involved in phenotypic variability and complex diseases.
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Significant differences at genome wide expression levels in 251
annotated genes (159 in males and 92 in females) and in allele fre-
quencies of 661 of the 2,800 nucleotide polymorphisms tested, were
observed. Differentially expressed genes from each constitution types
was found to be significantly enriched in core biological processes
like transport and regulation of cyclin dependent protein kinase
activity/immune response/regulation of blood coagulation. A signifi-
cant number of differentially expressed housekeeping, disease
associated and hub genes were observed in these extreme constitution
types which can have enormous systemic consequences. This suggests
that Ayurveda based method of phenotypic classification of extreme
constitutional types allows us to uncover genes that may contribute to
system level differences in normal individuals which could lead to
differential disease predisposition. This is a first attempt towards
unraveling the clinical phenotyping principle of a traditional system
of medicine in terms of modern biology. An integration of Ayurveda
with genomics holds potential and promise for future predictive
medicine.
498: Role of alcohol metabolizing genes in alcohol
induced pancreatitis
1Anuradha Pal, 1Suman Kapur, 1Shashwat Sharad,
1Manav Kapoor, 1Urvashi Dube, 2Anoop Saraya
1Birla Institute of Technology and Sciences (BITS), Biological
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Oxidant stress caused by alcohol metabolism is a common element
causing cellular injury in liver, pancreas, lung and brain. In order to
clarify the role of genetic factors in alcohol-related chronic pancre-
atitis among Indians, we determined single nucleotide polymorphisms
(SNPs) in the alcohol metabolizing genes prevalent in alcoholics and
control subjects. A total of 183 individuals were screened for
Arg47His in ADH1B, Ile349Val in ADH1C, Glu50Lys in ALDH2
gene and G1259C in CYP2E1 gene. Genotyping involved PCR–RFLP
based analysis. The control population satisfies the Hardy–Weinberg
equilibrium proportions (p \ 0.9). A significant association was seen
between 2-1/2-2 (Glu50Lys) allele of ALDH2 gene and alcohol use
(Fisher exact p value = 0.021). A significant association was also
seen between 2-2/2-2 (Glu50Glu) versus 2-1/2-2 (Glu50Lys) geno-
types of ALDH2 gene in alcoholic pancreatitis patients when
compared with unrelated controls (Odds Ratio (OR) = 10.5,
CI = 1.645–64.650, X2 = 4.546, p [ 0.03). The presence of ALDH2
2-2/2-2 genotype impacted the mean age of patients, p = 0.047,
t = 1.702 for 2-1/2-1 vs. 2-2/2-2. On the other hand ADH1B
(Arg47His) was found to be completely mono-morphic showing only
Arg47 as the prevalent allele (ADH 2-1/2-1). No difference was seen
in the prevalent alleles for ADH1B and ALDH2 genes among alco-
holics consuming nicotine along with alcohol or not. All the cases of
alcohol induced Pancreatitis were found to have the ancestral valine
allele for ADH1C. Three patients of alcoholic pancreatitis and one
with non-alcoholic pancreatitis were heterozygous for the G1259C
mutation in CYP2E1 gene, while none of the controls was found to
carry the mutated allele. The allele frequencies did not show any clear
trend with the clinical traits associated with alcohol induced pancre-
atitis, chronic pancreatitis and pancreatitis of unknown origin except
for ALDH2 gene polymorphism, which showed a significant reduc-
tion in the age of disease presentation in patients of alcoholic
pancreatitis.
499: Mitochondrial dysfunction: a major cause
for neuromuscular diseases
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Impairment of oxidative phosphorylation and normal physiology of
mitochondria leads to a number of mitochondrial disorders. The phe-
notypic consequences caused by the mitochondrial DNA variations are
manifested primarily in the major organs that require high-energy,
important one being the neuromuscular system. Indian population has a
very complex genetic architecture, which makes it suitable to study the
genetic diseases. Our study includes a total of 246 clinically diagnosed
individuals, having definite neuromuscular symptoms, and 300 age and
ethnically matched controls. Mitochondrial myopathies form the major
group of the patients consisting of 59 patients. 32 patients had multiple
system involvement; such as, cardiac, ophthalmic and gastrointestinal
symptoms. Complete mitochondrial DNA sequencing revealed a total
of 217 novel variants, distributed all along the mitochondrial genes,
however, majority of the mutations were found in ND5 gene. Interest-
ingly, none of the mutations was found in 300 controls. These mutations
were analyzed in the light of evolution and found that there is no specific
mitochondrial haplogroup associated with specific mitochondrial dis-
eases with neuromuscular symptoms. Tissue samples of 42 patients
were processed for histopathology and electron microscopy. Structural
and numerical abnormalities of the mitochondria were observed at least
50% of the cases. Modified Gomori Trichrome staining showed red
ragged fibers (RRF), a typical feature of mitochondrial diseases in 12
cases and some showed features of the denervation and RRF. This is the
first comprehensive study on the mitochondrial disorders in Indian
populations and a detailed clinical, histological, biochemical and
genetic data would be presented in detail during the meeting.
500: A study of A3243G mutation in mitochondrial
tRNALeu among Vietnamese MELAS patients
1Chi Phan Van, 1Nguyet Tran Thi Minh, 1Nhi Nguyen Bich,
2Anh Pham Thi Van, 3Hinh Le Duc
1Institute of Biotechnology (IBT), 18 Hoang Quoc Viet Rd, Hanoi,
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In this work, some results of study on the A3243G mutation in MT-
TL1 mitochondrial leucine tRNA gene from total blood DNA of
Vietnamese MELAS (Mitochondrial Encephalomyopathy with Lactic
Acidosis and Stroke) patients and its’ frequency are presented. Using
a pair of specific primers, the fragment gene with 400 bp in length
(from 3,095 nucleotide to nucleotide 3,494 in the mitochondrial
genome) was amplified and sequenced. The presence of A3243G
mutant was found by treatment of PCR product with ApaI restriction
enzyme and confirmed by both direct and indirect sequencing of the
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PCR products. The received sequences were aligned, analyzed,
compared with sequence NC_001907.3 in NCBI by BioEdit and
ClustalX (1.81) softwares. It was found also that this mutant was in
the heteroplasmy form with the frequency of about five percent. We
have also analyzed the serum proteome of the patients using combi-
nation of 2DE and nano liquid chromatography coupled on-line with
tandem mass spectrometry (nanoLC-ESI-MS/MS) to understand the
changes related to this type of mitochondrial disorder. More than ten
differently expressed proteins in the serum of the patients that might
be related to mitochondrial diseases were identified and need to be
further characterized. The results might enable us to a strategy to
discover new signs of mitochondrial diseases and identification of
novel biomarkers for MELAS disease.
501: Molecular pathogenesis of Parkin gene related
Parkinson’s disease in Indian population
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1S. N. Pradhan Centre for Neurosciences, University of Calcutta,
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Parkinson’s disease (PD), the second most common neurodegenerative
disorder, affecting at least 1% of the population over the age of
60 years. A total of 10 loci and eight causal genes have been identified
for PD. Among the identified genes largest number of mutations has
been detected in Parkin gene. In this study, a total of 384 PD patients,
with the mean age of onset being 48 ± 13 (age range, 5–78 years), and
105 controls were recruited for the study from eastern India. Mutations
were screened in Parkin by amplification of exons along with the
flanking splice junctions by polymerase chain reaction, single stranded
conformation polymorphism and DNA sequencing. A total of 21
nucleotide variants were detected in Parkin gene of PD patients; these
include six nonsynonymous changes (Gln34Arg, Arg42Cys, Arg42His,
Tyr143Cys, Arg334Cys and Gly359Asp) in heterozygous condition
and two homozygous deletions encompassing exons 3 and 4, and exons
8 and 9, in two unrelated families. Mutation in Parkin was identified in
7.55% cases. Two Parkin coding polymorphisms, Ser167Asn
(rs1801474) and Val380Leu (rs1801582), reported to be associated
with PD in different populations but with variable results, were found to
be significantly associated with PD cases in our cohort independent of
age of onset and sex. This study is supported by a grant from Council
and Scientific Research (CSIR), Govt. of India.
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in the Indian population from West Bengal
1Pampa Saha, 1Subhrangshu Guhathakurta, 1Rashmi Chandra,
1Swagata Sinha, 2Saurabh Ghosh, 1Anindita Chatterjee,
3Shabina Ahmed, 4Prasanta K. Gangopadhyay, 1Rajamma Usha
1Manovikas Kendra Rehabilitation and Research Institute for the
Handicapped, 482 Madudah, Plot I-24, Sector-J, EM Bypass, Kolkata
700 107, India, 2Indian Statistical Institute, 203 B.T. Road, Kolkata
700 108, India, 3Assam Autism Foundation, Amarwati Path, Christian
Basti, Guwahati 781 005, India, 4Calcutta National Medical College
and Hospital, 24, Gorachand Road, Kolkata 700 014, India
Autism is a neurodevelopmental disorder, characterized by impair-
ments in social interaction, communication and behavioral domains.
Family and twin studies indicate high heritability for autism with
involvement of more than 15 genes in an epistatic manner with non-
genetic factors. Among the various chromosomal regions identified as
autism susceptibility loci, chromosome 17q21 remains as one of them.
Disturbances of serotonin system and effectiveness of selective sero-
tonin reuptake inhibitors in treating behavioral deficits in autism has led
to the concept that genes that influence serotonin system are potential
risk loci for the disorder. At this juncture, ITGB3, the gene that codes
for integrin beta 3 and located on chromosome 17q21.32 can be
regarded as a candidate gene for the disorder as it is identified as
quantitative trait locus (QTL) for the whole blood serotonin level.
Various polymorphisms have been reported for ITGB3, of which T/C
single nucleotide polymorphism (SNP) in the exon 3 (rs5918) that
alters the 33rd leucine to proline of the protein and a A/C SNP
(rs15908) in the exon 9 gained maximum attention because of their
functional importance. Despite its importance, only one association
study is available on this gene with autism. So in the present study, we
have investigated genetic association of ITGB3 with autism spectrum
disorder (ASD) in the Indian population using population and family-
based studies. The probands were recruited through out patients
department (OPD) of Manovikas Kendra, Kolkata after psychometric
evaluation using DSM-IV criteria and assessment following CARS.
Genotyping analysis was carried out for two SNPs, rs5918 and rs15908
in 84 ASD patients, 148 parents and 88 controls and genotypes showed
conformation to Hardy–Weinberg equilibrium. Case–control associa-
tion study on subjects from West Bengal based on allelic and genotypic
frequencies did not demonstrate any significant overrepresentation in
either the controls or the cases. This result was further supported by the
family-based investigation, which also failed to show any preferential
transmission of the alleles from parents to the affected offspring. Thus,
the present preliminary study on the Indian population suggests a lack
of association of the two SNP markers with ASD. In order to justify our
present result, it warrants further studies involving more sample size
and markers.
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promoter and the leptin receptor gene in a sample
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Introduction: Brain-derived neurotrophic factor (BDNF) is expressed
predominantly in the ventromedial hypothalamus and its expression is
nutritionally regulated by leptin at least in the dorsomedial hypo-
thalamus. Recently, original studies in murine and non-human
primates models have shown that mutations in neurotrophin brain-
derived neurotrophic factor (BDNF) inhibits food intake, and BDNF
disruption exhibit increased food intake and obesity. Furthermore,
mutations and polimorphisms Iin BDNF has been linked to neuro-
logical, psychiatric, anorexia and cachexia. Those finding and linkage
studies suggest that BDNF could be a susceptibility gene to obesity.
Objective: Investigated the relationship of polymorphism localized in
BDNF gene with body mass index (BMI), in a sample of obesity
Mexican patiens.
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Methods: We perfomed a case–control association study in 280 obese
cases with a BMI[30 and 275 controls with a BMI\25. We analyzed
rs6265, rs1519480, rs7934165, rs11030102, rs7124442, rs7124442
and rs104822. Genotyping was carried out by 50 exonuclease assay
(TaqMan).The association test, Hardy–Weinberg equilibrium (H–
WE) and haplotypes were determined using EPIDAT, FINETTI and
Haploview softwares, respectively.
Results: The allelic and genotype frequencies in cases and controls
were in H–WE. In this study we only observed a significantly asso-
ciation of the K109R polymorphism from the LEPR with BMI
(P = 0.01, OR = 0.1.67; 95% CI: 1.089–2.492).
Conclusion: Our preliminary results suggests that the polymorphism
K109R in the LEPR gene could be a susceptibility factor risk to
development obesity in Mexican population.
504: Role of SNAP25 genetic polymorphisms
in the etiology of attention deficit hyperactivity
disorder in eastern Indian subjects
Kanyakumarika Sarkar, Swagata Sinha, Anindita Chattopadhyay,
Kanchan Mukhopadhyay
Manovikas Biomedical Research and Diagnostic Centre, 482,
Madudah, Plot I-24, Sector J, Eastern Metropoliton Bypass,
Kolkata-700107, India
ADHD is a highly heritable childhood onset neuropsychiatric dis-
order characterized by inattention, hyperactivity, impulsivity and
distractibility. Accordingly, the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) [APA, 1994] describes three subtypes
of ADHD: inattentive, hyperactive-impulsive and combined. Imag-
ing studies have confirmed reduction in the prefrontal cortical region
of ADHD patients. This area is rich in dopaminergic innervations
and therefore, candidate gene search for ADHD is mainly targeted at
the dopaminergic system. Dopamine is produced in several areas of
the brain including substantia nigra and hypothalamus and acts on
the sympathetic nervous system. Release of dopamine is controlled
by presynaptic fusion of vesicles, which is governed by Ca2+/Cal-
modulin dependent exocytosis. Synaptosomal-associated protein-25
(SNAP-25), synaptobrevin and syntaxin have function in vesicle
docking and fusion. Several SNPs in the SNAP25 gene have been
reported to be associated with ADHD in different ethnic groups
worldwide. A homozygous deletion in the murine SNAP25 gene
was reported to be lethal and hemizygous deletion resulted in
hyperactive phenotype similar to ADHD. However, till date
SNAP25 gene polymorphisms have not been studied in Indian
ADHD patients. In the present investigation two SNPs in the
SNAP25, rs362988 and rs8636, were studied in eastern Indian
children/adolescents suffering from ADHD (n = 98). Patients were
recruited based on the DSM-IV criteria. Genomic DNA was isolated
from peripheral blood collected after obtaining informed written
consent. The SNP at exon 6, rs362988, was genotyped by PCR
amplification followed by sequence analysis. The SNP rs8636 at the
exon 8 was analyzed by PCR amplification followed by restriction
digestion with HpyCH4IV. Case–control analysis revealed lack of
significant difference between the two groups (p [ 0.05) for both
the polymorphisms. Family-based association analysis also failed to
show any significant association of these polymorphic alleles with
the disorder. It can be concluded from the present study, that the
rs362988 and rs8636 are not contributing to the etiology of ADHD
in the studied population.
Acknowledgement: This work was sponsored by the Board of
Trustees, Manovikas Kendra, Kolkata.
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Aim: Sex steroid receptors have been reported in ocular tissues.
However, their clear role in eye development or ocular disorders has
yet to be elucidated. Many studies have shown that glucocorticoids
can lower lens glutathione (reduced) content, which has been dem-
onstrated to be associated with various forms of cataract.
Progesterone is indirectly involved in synthesis of glucocorticoids.
Thus progesterone may play an indirect role in development of steroid
induced cataract. The present study is an attempt to associate varia-
tions with the incidence and progression of cataract. The particular
mutation under study lies in the promoter region of CRYGB gene and
is predicted to impact the binding of progesterone receptor.
Methods: Total of 137 healthy volunteers and 272 (113 pediatric and
79 senile) cataract cases from western India were studied. Examina-
tion was performed so as to include volunteers with no ocular defects
as controls and cases less than 12 and greater than 45 years of age
diagnosed with cataract (excluding metabolic and traumatic cataract
cases). PCR–RFLP based method was employed for genotyping of
G198A (Intron A), T196C (Exon 3) of CRYGA and C-47T (Pro-
moter), G449T (Exon 2) of CRYGB genes.
Results: Allele frequency of -47T of CRYGB varied significantly
(v2 = 5.66, P = 0.02) among different age groups and also in cases
verses controls (OR: 2.9; CI = 1.24–6.47, P = 0.01). An in silico
analysis reveals that the mutation in CRYGB promoter impacts the
binding of transcription factor, PR (Progestrone Receptor) that may
lead to altered expression of CRYGB. Stratification of samples
according to gender also showed males and females below 12 years of
age having a natural protection against cataract in the presence of
mutated allele.
Conclusions: This study provides the first report of a SNP affecting
the role of progesterone receptor and its protective role in cataract.
The data provides strong basis for further studies on role of sex ste-
roid hormones effecting c-crystallin locus in ocular defects and may
shed more light on a natural basis for genetic protection from pedi-
atric cataract in population from India.
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2A gene (HTR2A) with autism spectrum disorder
(ASD): a genetic study on Indian population
1Asem Surendro Singh, 1Subhrangshu Guhathakurta,
1Swagata Sinha, 1Anindita Chatterjee, 2Shabina Ahmed,
3Saurabh Ghosh, 4Prasanta K. Gangopadhyay, 1Rajamma Usha
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Amarwati Path, Christian Basti, Guwahati 781 005, India, 3Indian
Statistical Institute, 203 B.T. Road, Kolkata 700 108, India, 4Calcutta
National Medical College and Hospital, 24, Gorachand Road, Kolkata
700 014, India
Abnormality in serorotoninergic neurotransmission is one of the most
consistant findings in autism and serotonin receptors act as mediators
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for this process. Biochemical studies using 3H-Lysergic Acid
Diethylamide(3H-LSD) provides substantial evidences for the
involvement of 5-HT2A receptor in autism. Therefore, HTR2A, the
gene that codes for serotonin receptor2A (5-HT2A) is considered as a
candidate gene for autism. The location of the gene near to a sug-
gestive autism linkage region on chromosome 13q further supports
this hypothesis. Three polymorphisms i.e., A/G single nucleotide
polymorphysm at 1438 bp upstream of transcription start site
(A-1438G), T/C SNP in exon 1 (T102C) and C/T SNP in exon 3
(C1354T) are given much attention in various neuropsychiatric dis-
orders. However, apart from two studies on American and Korean
populations, no further reports are available on association of this
gene with autism. Therefore, the present study investigates the
association of HTR2A gene with autism spectrum disorders in the
Indian population following population and family-based analyses.
Autistic children were recruited through out patients department of
the institute after psychometric evaluations using the DSM-IV criteria
and the CARS is used as the assessment tool. Genotyping was carried
out for 115 probands, 206 parents and 102 control subjects after PCR
and RFLP analysis using the genomic DNA isolated from the white
blood cells. The genotypes of all the groups conformed to Hardy–
Weinberg Equilibrium. The population-based analysis did not show
any bias in the genotypic or allelic distribution between the cases and
the controls from West Bengal region. The family-based investigation
failed to show any preferential transmission of the alleles from par-
ents to affected offspring supporting the case–control finding. Thus,
the present study suggests that the HTR2A markers are unlikely to be
associated with the disorder in the Indian population.
507: Epistatic interactions in psychiatric disorders
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Genetic correlates of disease of complex inheritance may include
variations in several genes lying within a network of linked biological
processes. Synaptic mechanisms such as serotonin neurotransmission,
and second (third) messengers (e.g., GSK) have both been implicated
in susceptibility to mood disorder, the actions of drugs used to treat
the syndrome, and manipulation of the circadian rhythms. To study
association between these systems and BPAD, we analyzed two
single nucleotide polymorphisms (SNPs) in HTR2A gene (T102C
(rs6313), His452Tyr (rs6314)), one SNP in SLC6A4 (5HTTLPR
promoter region)), and a promoter SNP in GSK3B gene, -50T/C
(rs334558), in 186 BPAD individuals (M:F = 1:1; mean age at onset
18.38 ± 5.43) and matched controls (M:F = 1:1). We examined the
epistatic interactions between the SNPs, using MDR (multifactor
dimensionality reduction) method. The results suggested modestly
synergistic interactions between the loci. MDR detected a two locus
model involving 5HTTLPR and rs334558 (GSK3B) with maximum
cross validation consistency and minimum prediction error (Monte
Carlo p = 0.008). LL/TT and SS/TC genotype combinations were
observed to possibly confer significant risk towards BPAD. The
heterozygous loci, on the other hand seemed to modestly protect,
suggesting a heterozygote advantage. Our results suggested an
interplay between the synaptic transmission pathway involving
serotonin and the post synaptic sequestration of the neurotransmitter,
and the second messenger system involving GSK. This could have an
important implication in the biology of complex disorders, like mood
disorders.
508: Is C-A substitution in exon-2 of CRYAA gene
(F71L) causally related to age-related cataracts?
1BhagyaLaxmi Sukka Ganesh, 1Padma Tirunilai,
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The aim of the study is to investigate the molecular variation in the
exon-2 of alpha crystallin (CRYAA) among the patients of age-
related cataracts.
A total of 452 age-related cataract patients with different types of
cataracts (nuclear (NC)-108; cortical (CC)-105; posterior subcapsular
(PSC)-95; mixed type (MT)-144 cataracts) and 148-healthy normal
age-matched controls were screened for mutations in Ex-2 of CRYAA
gene. The genomic DNA isolated from the blood samples of patients
and controls were amplified using specific primers of Ex-2 of CRY-
AA gene. The resulting PCR product (223 bp) was checked for
amplification on 1% agarose gel and subjected to SSCP analysis. The
samples showing mobility shift were recorded.
Of the different types of age-related cataracts studied three patients,
two with NC and one with MT showed mobility shift pattern by the
SSCP analysis. On sequencing, substitution of C-A at position 213
(counting the A of the start codon as number-1) in Ex-2 of CRYAA
gene was detected in all the three cases while among controls none of
the samples showed the mutation. This nucleotide change resulted in
the substitution of phenylalanine (TTC) to leucine (TTA) at amino
acid position 71 (F71L) probably altering the protein structure.
The pathogenicity of this putative mutation leading to cataract
formation has to be explored. It is likely that this mutation may be
altering the molecular chaperon activity of CRYAA gene leading to
protein aggregation and cataract formation. Mutations in CRYAA
gene are known to be associated with phenotypically different types
of congenital cataracts, with varied progression and inheritance while
in age-related cataracts, mutations in the CRYAA gene are not yet
reported. The mutation found in the present study could be the first
one in the Indian population.
509: Exploring the molecular association
of transthyretin amyloidosis with spinocerebellar
ataxia and glaucoma
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Amyloidosis is a condition, which involves deposition of abnormally
folded protein aggregates (amyloid) in various tissues. Transthyretin
(TTR) amyloidosis, a late-onset autosomal dominant disorder is the
most common form of hereditary amyloidosis characterized by amyloid
deposition in peripheral nerves, heart, kidney, gastrointestinal tract and
eye. TTR, a homo-tetramer in its native form is involved in the transport
of thyroxine and retinol. TTR is predominantly synthesized in liver but
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is also expressed in several other sites including choroid plexus of the
brain, retinal pigment of the eye, pancreatic islets and pineal glands.
Over 100 TTR variations have been identified and majority of these are
associated with TTR amyloidosis. These amyloidogenic mutations in
TTR interfere with the stability of the native tetramer by inducing
conformational changes that trigger its dissociation into partially
unfolded conformers that may self-associate to form amyloid fibrils.
Several independent case reports suggest association of TTR mutations
with many other neurodegenerative disorders including Alzheimer’s,
spinocerebellar ataxia (SCA), glaucoma and diabetes. To establish an
association between TTR amyloidosis and other neurodegenerative
disorders, we have sequenced TTR gene in 100 spino-cerebellar ataxia
patients with peripheral neuropathy and 100 primary open angle glau-
coma patients. So far, we have identified four variations in these sample
sets. Interestingly, two of these are novel variations that are predicted to
affect splicing. The reported non-synonymous c.76G [ A variation
(p.Gly26Ser) in exon-2 is a non-amyloidogenic variation in TTR, which
affects thyroxine binding. We observed this variation in one out of 74
SCA12 samples, 3 out of 89 uncharacterized ataxia samples and 1 out of
169 control samples. We are now screening larger sample cohorts of
ataxia and glaucoma as well as analyzing the variants in control sam-
ples. The findings and the role of these TTR variations in
spinocerebellar ataxia and glaucoma will be discussed in the meeting.
510: PAX6 interacts with SPARC, Ras and P53
that links Akt and TGFbeta pathways and influences
on neural functions in brain
Ratnakar Tripathi, Rajnikant Mishra
Banaras Hindu University, Varanasi, India
The PAX6 is one of the critical transcriptional regulator for the
development of brain, eyes, islets of pancreas. The involvement of
PAX6 in neural development is well known but the knowledge about
its interaction with other proteins during development and disease is
limited. Predicting interaction of PAX6 like any other protein with
specificity is largely an unsolved problem. It is also not clear how
mutation of the PAX6 gene results in various phenotypes and why the
phenotypes are of variable expressivity. We explore PAX6 interactors
through co-immunoprecipitation. It was interesting to observe a ma-
tricellular protein, SPARC, interacting with PAX6. Immunoreactive
bands with Ras and P53 were also detected in the sample of brain
immunoprecipitated with anti-PAX6. We also present models of
PAX6 interacting protein through on-line servers STRING and PIP.
This article elucidates putative interaction network of PAX6. It also
provides insight to associated proteins in the cascade of hierarchy of
PAX6 transcription factor. It is presumed that PAX6 interacts with
SPARC, Ras and P53 that links Akt and TGFbeta pathways and
influences on neural functions in brain.
511: A descriptive study of the prevalence of factor V
(F5) 1691G [ A, prothrombin (F2) 20210G [ A
and methylenetetrahydrofolate reductase (MTHFR)
677C [ T polymorphisms among patients with
thromboembolism in the Sri Lankan population
L. Y. Weerasekera, H. W. W. Goonasekera, R. W. Jayasekara,
V. H. W. Dissanayake
Human Genetics Unit, Faculty of Medicine, University of Colombo,
Kynsey Road, Colombo 08, Sri Lanka
Introduction: Three well known genetic thrombophilic polymor-
phisms have been described—F5 1691G [ A, F2 20210G [ A and
the MTHFR 677C [ T. The objective of this report is to the report the
prevalence of the variant alleles of these polymorphisms in Sri Lan-
kan patients with thromboembolism and their family members tested
in Colombo, Sri Lanka.
Method: DNA was extracted from venous blood samples after
obtaining written informed consent and genotyped using standard
PCR/RFLP methods.
Results: A total of 577 people were tested. They consisted of 71
(12%) with cerebrovascular events (CVE); 22 (4%) with arterial
thrombosis in other sites (ATO); 58 (10%) with venous thrombosis in
other sites (VTO)); 419 (73%) with pregnancy complications (PC)
239 (57%) with recurrent spontaneous pregnancy loss, 175 (42%)
with pre-eclampsia (PE); 3(1%) with intrauterine death; 1 (0.5%) each
of abruptio placentae and intrauterine growth restriction, and 7 (1%)
healthy family members of people with thrombophilic genetic vari-
ants tested as a part of pre-symptomatic family screening (PS). The
variant allele frequencies were as follows: F5 1691A: CVE—1(1%);
ATO—1(1%); VTO—2(2%); PC—11(1%); and PS—3(29%); F5
20210A: CVE—0(0%); ATO—0 (0%); VTO—1 (1%); PC—0(0%);
and PS—0(0%); MTHFR 677T: CVE—17(7%); ATO—5 (14%);
VTO—15 (14%); PC—91(11%); and PS—2 (14%).
The MTHFR 677TT genotype was present in 6 with CVE, 7 with
PC and 2 in pre-symptomatic family members. The only F5 1691AA
genotype was detected in a pre-symptomatic woman screened as part
of family screening. Conclusions: The prevalence of the variant
alleles of these polymorphisms in the Sri Lankan population is similar
to that of other South Asian populations. This data will help plan
future thrombophilia testing protocols as well as underscore the
importance of including family screening as part of genetic testing
protocols.
512: A susceptibility locus for juvenile absence epilepsy
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In complex disorders like epilepsy, susceptibility is a result of a
combination of mutations or polymorphisms which cause small
changes in the expression of certain genes or in the function of the
protein. Solely the subtle changes may not lead to any disease and
they may be found in unaffected individuals. Moreover, affected
individuals may be carrying different susceptibility genes which
cause changes in the disease phenotype and this explains the phe-
notypic difference within the same family. Juvenile absence epilepsy
(JAE) and childhood absence epilepsy (CAE) are subtypes of Idio-
pathic generalized epilepsy (IGE) that show complex inheritance with
incomplete penetrance. Genome-wide linkage studies resulted in
strong disease locus on chromosome 5, 3q26, 8q24 and susceptibility
locus on 14q23 and 2q36. Candidate gene approach resulted in
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identification of mutations in GABAA receptor (5q31.1–33.1), volt-
age-gated Ca? 2 channel (19p13) and CI channel (3q26) in three
different families. In absence mouse models (tottering, lethargic,
stargazer), mutations have been identified in three Ca?? channels
genes; Cacna1a, Cacnab4 and Cacnag2 which encode a1A, b4, c2
voltage-dependent Ca?? channel subunit isoforms, respectively.
Genome-wide linkage analysis in absence rat models on the other
hand, resulted in a susceptibility locus in syntenic 2q33-37 chromo-
somal region. The present study involves an association study carried
out on 213 IAE patients and 214 healthy controls using 10 SNPs in
the 2q36 susceptibility region. The SNP selection was based on a
haplotype block analysis of the region in the Turkish population. The
genotyping was done on Lightcycler 480 and the results were eval-
uated by Haploview version 4. In the analysis of subtypes, two SNPs
were found to be highly associated with JAE phenotype with p-values
0.0029 and 0.0165. Future studies will focus on the search for pos-
sible causative mutations or common polymorphisms in the
associated region.
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